Arvinas Inc (ARVN)
35.23
0.00 (0.00%)
USD |
NASDAQ |
May 24, 16:00
35.23
0.00 (0.00%)
After-Hours: 20:00
Arvinas Debt to Equity Ratio: 0.0011 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.0011 |
| December 31, 2023 | 0.0012 |
| September 30, 2023 | 0.0022 |
| June 30, 2023 | 0.0022 |
| March 31, 2023 | 0.002 |
| December 31, 2022 | 0.0018 |
| September 30, 2022 | 0.0016 |
| June 30, 2022 | 0.0015 |
| March 31, 2022 | 0.0014 |
| December 31, 2021 | 0.0013 |
| September 30, 2021 | 0.0012 |
| June 30, 2021 | 0.0017 |
| March 31, 2021 | 0.0033 |
| Date | Value |
|---|---|
| December 31, 2020 | 0.0031 |
| September 30, 2020 | 0.0098 |
| June 30, 2020 | 0.0101 |
| March 31, 2020 | 0.0094 |
| December 31, 2019 | 0.0088 |
| September 30, 2019 | 0.0149 |
| June 30, 2019 | 0.0178 |
| March 31, 2019 | 0.0165 |
| December 31, 2018 | 0.0158 |
| September 30, 2018 | 0.0604 |
| June 30, 2018 | 0.0053 |
| March 31, 2018 | |
| December 31, 2017 | 1.262 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0011
Minimum
Mar 2024
0.0178
Maximum
Jun 2019
0.0048
Average
0.0021
Median
Debt to Equity Ratio Benchmarks
| Pfizer Inc | 0.7445 |
| Johnson & Johnson | 0.4803 |
| Bristol-Myers Squibb Co | 3.376 |
| Janux Therapeutics Inc | 0.00 |
| ACADIA Pharmaceuticals Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.213B |
| Total Liabilities (Quarterly) | 602.90M |
| Shareholders Equity (Quarterly) | 609.70M |
| Current Ratio | 4.943 |
| Net Debt Paydown Yield | 0.00% |